PulseSelect™ PFA Global Registry
ConditionAtrial Fibrillation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedtronic Cardiac Ablation Solutions
About this trial
The PulseSelect™ PFA Global Registry is a prospective, global, multi-center, observational post-approval study. Subjects will be treated with the PulseSelect™ PFA System and followed according to SOC.
Eligibility criteria
Qualifiers
Subject is ≥ 18 years of age or minimum age as required by local regulations.
Subject has been diagnosed with atrial fibrillation (AF)
Planned procedure using commercially available PulseSelect™ PFA System.
Willing to comply with study requirements and give informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements.
Disqualifiers
Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study manager.
Subject with exclusion criteria required by local law.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov